Mice transgenic for Alzheimer disease β-amyloid develop lens cataracts that are rescued by antioxidant treatment

被引：67

作者：

Melov, S

Wolf, N

Strozyk, D

Doctrow, SR

Bush, AI

机构：

[1] Buck Inst Age Res, Novato, CA 94945 USA

[2] Univ Washington, Dept Pathol, Seattle, WA 98195 USA

[3] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10462 USA

[4] Eukarion, Bedford, MA 01730 USA

[5] Harvard Univ, Sch Med, Massachusetts Gen Hosp East, Lab Oxidat Biol,Genet & Aging Res Unit, Charlestown, MA 02129 USA

[6] Harvard Univ, Sch Med, Massachusetts Gen Hosp East, Dept Psychiat, Charlestown, MA 02129 USA

[7] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia

[8] Univ Melbourne, Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia

来源：

FREE RADICAL BIOLOGY AND MEDICINE | 2005年 / 38卷 / 02期

关键词：

free radicals;

D O I：

10.1016/j.freeradbiomed.2004.10.023

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Alzheimer disease is characterized by cerebral A deposition, which we have recently discovered occurs also in the lens as cataracts in Alzheimer disease patients. Here we report the presence of significantly increased cataracts in the lenses of an Abeta-transgenic mouse model for Alzheimer disease and their amelioration upon treatment with EUK-189, a synthetic SOD/catalase mimetic. These data support an oxidative etiology for AD-associated lens cataracts and their potential to be treated preventatively with antioxidants. (C) 2004 Elsevier Inc. All rights reserved.

引用

页码：258 / 261

页数：4

共 50 条

[1] Aβ peptides in human and amyloid-bearing transgenic mouse lens:: Implications for Alzheimer's disease and cataracts.
Goldstein, L
Muffat, J
Cherny, R
Faget, K
Coccia, J
Fraser, F
Masters, C
Tanzi, R
Chylack, L
Bush, A
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S299 - S299
[2] Amyloid transgenic mice: An incomplete model of Alzheimer's disease
McGeer, PL
Schwab, C
Hosakawa, M
Staufenbiel, M
NEUROBIOLOGY OF AGING, 2002, 23 (01) : S234 - S235
[3] MR Microimaging of amyloid plaques in Alzheimer’s disease transgenic mice
Thomas M. Wengenack
Clifford R. Jack
Michael Garwood
Joseph F. Poduslo
European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 82 - 88
[4] MR Microimaging of amyloid plaques in Alzheimer's disease transgenic mice
Wengenack, Thomas M.
Jack, Clifford R., Jr.
Garwood, Michael
Poduslo, Joseph F.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (Suppl 1) : S82 - S88
[5] Immune hyporesponsiveness to amyloid β-peptide in amyloid precursor protein transgenic mice:: Implications for the pathogenesis and treatment of Alzheimer's disease
Monsonego, A
Maron, R
Zota, V
Selkoe, DJ
Weiner, HL
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) : 10273 - 10278
[6] Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease
Schwab, C
Hosokawa, M
McGeer, PL
EXPERIMENTAL NEUROLOGY, 2004, 188 (01) : 52 - 64
[7] Quantitative neuropathological assessment of Alzheimer disease and amyloid precursor protein transgenic mice
Irizarry, MC
Gomez-Isla, T
Gomez-Tortosa, E
Hyman, BT
FRONTIERS OF THE MECHANISMS OF MEMORY AND DEMENTIA, 2000, (1200): : 133 - 136
[8] Imaging brain amyloid of Alzheimer disease in vivo in Transgenic mice with an Aβ peptide radiopharmaceutical
Lee, HJ
Zhang, Y
Zhu, CN
Duff, K
Pardridge, WM
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (02): : 223 - 231
[9] Transgenic mice expressing Alzheimer amyloid precursor proteins
Hsiao, K
EXPERIMENTAL GERONTOLOGY, 1998, 33 (7-8) : 883 - 889
[10] PROCESSING OF THE ALZHEIMER AMYLOID PRECURSOR PROTEIN IN TRANSGENIC MICE
BORCHELT, D
THINAKARAN, G
JOHANNSDOTTIR, R
PRICE, D
SISODIA, S
HSIAO, K
JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 102 - 102

← 1 2 3 4 5 →